Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 41 citing articles:

Alzheimer’s Disease: An Update and Insights Into Pathophysiology
Murtala Bello Abubakar, Kamaldeen Olalekan Sanusi, Azizah Ugusman, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 160
Signal pathways in the treatment of Alzheimer’s disease with traditional Chinese medicine
Min-Rui Ding, Yan-Jie Qu, Bing Hu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113208-113208
Open Access | Times Cited: 83
The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target
Marta Rusek, Joanna Smith, Kamel El-Khatib, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 864-864
Open Access | Times Cited: 64
Disease trajectory browser for exploring temporal, population-wide disease progression patterns in 7.2 million Danish patients
Troels Siggaard, Roc Reguant, Isabella Friis Jørgensen, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 92
Alzheimer’s disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
Kevin Mullane, Michael Williams
Biochemical Pharmacology (2020) Vol. 177, pp. 113945-113945
Closed Access | Times Cited: 85
Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease
Eunshil Lee, Yongmin Chang
Cells (2025) Vol. 14, Iss. 3, pp. 168-168
Open Access | Times Cited: 1
Single-cell peripheral immunoprofiling of Alzheimer’s and Parkinson’s diseases
Thanaphong Phongpreecha, Rosemary Fernandez, Dunja Mrdjen, et al.
Science Advances (2020) Vol. 6, Iss. 48
Open Access | Times Cited: 42
Characterization of the chromatin accessibility in an Alzheimer’s disease (AD) mouse model
Yaqi Wang, Xiaomin Zhang, Song Qiao, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 40
Biomedical discovery through the integrative biomedical knowledge hub (iBKH)
Chang Su, Yu Hou, Manqi Zhou, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106460-106460
Open Access | Times Cited: 15
Hydroxychloroquine lowers Alzheimer’s disease and related dementias risk and rescues molecular phenotypes related to Alzheimer’s disease
Vijay R. Varma, Rishi Desai, Sheeja Navakkode, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 3, pp. 1312-1326
Open Access | Times Cited: 22
Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature
Sandra Maria Barbalho, Beatriz Leme Boaro, Jéssica da Silva Camarinha Oliveira, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 133-133
Open Access
Characterization of gene expression profiles in Alzheimer’s disease and osteoarthritis: A bioinformatics study
Nian Liu, Qian Deng, Zining Peng, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0316708-e0316708
Open Access
Reconstructed Cell-Type Specific Rhythms in Human Brain link Alzheimer's Pathology, Circadian Stress, and Ribosomal Disruption
Henry C. Hollis, Ashish Sharma, Patrick W. Sheehan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Identification and Exploration of Immunity‐Related Genes and Natural Products for Alzheimer's Disease Based on Bioinformatics, Molecular Docking, and Molecular Dynamics
Pengpeng Liang, Chang Ye Yale Wang, J Liu, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 4
Open Access
PrGeFNE: Predicting disease-related genes by fast network embedding
Ju Xiang, Ningrui Zhang, Jiashuai Zhang, et al.
Methods (2020) Vol. 192, pp. 3-12
Closed Access | Times Cited: 32
Real-world studies: bridging the gap between trial-assessed efficacy and routine care
Daohong Chen
Journal of Biomedical Research (2022) Vol. 36, Iss. 3, pp. 147-147
Open Access | Times Cited: 18
Interleukin 22 and its association with neurodegenerative disease activity
Wenjian Chen, Jianpeng Wang, Huaizhi Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
Staging Alzheimer’s Disease in the Brain and Retina of B6.APP/PS1 Mice by Transcriptional Profiling
Sumana R. Chintapaludi, Aslı Uyar, Harriet M. Jackson, et al.
Journal of Alzheimer s Disease (2020) Vol. 73, Iss. 4, pp. 1421-1434
Open Access | Times Cited: 21
Replication study of plasma proteins relating to Alzheimer's pathology
Liu Shi, Laura Winchester, Sarah Westwood, et al.
Alzheimer s & Dementia (2021) Vol. 17, Iss. 9, pp. 1452-1464
Open Access | Times Cited: 19
Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems
Devank Shekho, Ritika Mishra, Raj Kamal, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 7
Closed Access | Times Cited: 2
Exploring links between 2‐oxoglutarate‐dependent oxygenases and Alzheimer's disease
Haotian Liu, Yong Xie, Xia Wang, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 12, pp. 2637-2668
Open Access | Times Cited: 11
The interference between SARS-COV-2 and Alzheimer’s disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic
Heba M. Mansour
Ageing Research Reviews (2024) Vol. 94, pp. 102195-102195
Closed Access | Times Cited: 2
Revealing genetic links of Type 2 diabetes that lead to the development of Alzheimer’s disease
Muhammad Afzal, Khalid Saad Alharbi, Sami I. Alzarea, et al.
Heliyon (2022) Vol. 9, Iss. 1, pp. e12202-e12202
Open Access | Times Cited: 10
Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer’s disease through a network pharmacology approach
Yan-Jie Qu, Rong-Rong Zhen, Limin Zhang, et al.
BMC Complementary Medicine and Therapies (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 15
Signalling Pathways Involved in Microglial Activation in Alzheimer’s Disease and Potential Neuroprotective Role of Phytoconstituents
Mohd Uzair Ali, Laiba Anwar, Mohd Humair Ali, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 23, Iss. 7, pp. 819-840
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top